Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Triton in connection with the acquisition of Prenax
Mandate

Vinge advises Triton in connection with the acquisition of Prenax

July 01, 2025 M&A Contentious Regulatory Banking and Finance Commercial Agreements Employment and Benefits IT, Telecommunications and Outsourcing Data protection and processing of personal data Intellectual Property Real Estate and Construction

Vinge has advised Triton Smaller Mid Cap Fund II in connection with the acquisition of Prenax from LBO France and certain minority shareholders.

Prenax is a leading subscriptions management service provider. The company was founded in 1993 and today manages the administration of over 340,000 subscriptions on behalf of its clients. Prenax has offices in 11 countries across the UK & Benelux, the Nordics, Southern Europe, the US, and Australia. 

The transaction is subject to regulatory approvals.

Vinge’s team mainly consisted of Johanna Wiberg, Egil Svensson, Michella Lina Said and Hedvig Merkel (M&A), David Olander and Lovisa Arpi (Regulatory), August Ahlin (Banking and Finance), Mario Saad and Jacob Eberil (Agreements), William Karo Persson (Employment), Carla Håkansson (IT), Siri Blomberg (GDPR), Arvid Axelryd and Melinda Oldenburg (IP), Simon Gille-Johnson (Real Estate), Hayaat Ibrahim (Compliance), Diana Kanold (Transaction Support Coordinator).

Read the client’s press release.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025